are semaglutide and glp-1 the same thing vs. GLP-1: Understanding Key Differences Semaglutide vs GLP-1: Key Differences

The TRIUMPH-4 Phase 3 data provides the most current safety information: Nausea: 38.1% (9 mg) to 43.2% (12 mg) versus 10.7% placebo Diarrhea: 34.7% (9 mg) to 33.1% (12 mg) versus 13.4% placebo Constipation: 21.8% (9 mg) to 25.0% (12 mg) versus 8.7% placebo Vomiting: 20.4% (9 mg) to 20.9% (12 mg) versus 0% placebo Decreased appetite: 19.0% (9 mg) to 18.2% (12 mg) versus 9.4% placebo The pattern is clear

However, as with any surgery, there are risks involved

Semaglutide is a GLP-1 receptor agonist, while Tirzepatide is a dual GIP and GLP-1 receptor agonist

As the table shows, the all-inclusive model offered by dedicated platforms provides a blend of affordability and comprehensive care that is often the most practical and effective path for most people

They are also reducing or stopping their insulin